Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Clinical trial NCT04501406 · RECRUITING

Trial details

NCT number: NCT04501406
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis

Start date: 2020-12-15
Primary completion: 2027-08-31
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.